Retinoid-mediated regulation of mood: Possible cellular mechanisms

Experimental Biology and Medicine

Volumn 233, Issue 3, 2008, Pages 251-258

  O'Reilly, Kally ^a   Bailey, Sarah J ^b   Lane, Michelle A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b University of Bath   (United Kingdom)

Author keywords

Depression; Monoaminergic; Neurogenesis; Retinoid

Indexed keywords

ISOTRETINOIN; RETINOID;

CELL FUNCTION; DEPRESSION; DOPAMINERGIC SYSTEM; HUMAN; MOOD; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; SEROTONINERGIC SYSTEM; SHORT SURVEY; SIGNAL TRANSDUCTION;

AFFECT; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; HUMANS; NEURONS; RETINOIDS; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 40149086413     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0706-MR-158     Document Type: Short Survey

References (79)

1. Maden M. Retinoid signaling in the development of the central nervous system. Nat Rev Neurosci 3:843-853, 2002.
2. Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery PJ. 13-Cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci U S A 101:5111-5116, 2004.
3. Lane MA, Bailey SJ. Role of retinoid signaling in the adult brain. Prog Neurobiol 72:275-293, 2005.
4. Mey J, McCaffery P. Retinoic acid signaling in the nervous system of adult vertebrates. Neuroscientist 10:409-421, 2004.
5. Hull PR, D'Arcy C. Isotretinoin use and subsequent depression and suicide. Am J Clin Dermatol 4:493-505, 2003.
6. Starling J, Koo J. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. J Drugs Dermatol 4: 690-696, 2005.
7. Vogel S, Gamble MV, Blaner WS. Biosynthesis, absorption, metabolism and transport of retinoids. In: Nau H, Blaner WS, Eds. Retinoids: The Biochemical and Molecular Basis of Vitamin A and Retinoid Action. Berlin Heidelberg: Springer-Verlag, pp31-95, 1999.
8. Tsukada M, Schroder M, Roos TC, Chandraratna RAS, Reichert U, Mark HF, Orfanos CE, Zouboulis CC. 13-Cis-retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans-retinoic acid and binding to retinoic acid receptors. J Invest Dermatol 115:321-327, 2000.
9. Idres N, Marill J, Flexor MA, Chabot GG. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem 277:31491-31498, 2002.
10. O'Reilly K, Trent S, Bailey SJ, Lane MA. 13-Cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor and serotonin reuptake transporter levels in vitro. Exp Biol Med 232:1195-1203, 2007.
11. Zetterstrom RH, Lindqvist E, Mata de Urquiza A, Tomac A, Eriksson U, Perlmann T, Olson L. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11:407-416, 1999.
12. McCaffery PJ, Drager UC. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci U S A 91:7772-7776, 1994.
13. Thompson Haskell G, Maynard TM, Shatzmiller RA, Lamantia AS. Retinoic acid signaling at sites of plasticity in the mature central nervous system. J Comp Neurol 452:228-241, 2002.
14. Wagner E, Luo T, Drager UC. Retinoic acid synthesis in the postnatal mouse brain marks distinct developmental stages and functional systems. Cereb Cortex 12:1244-1253, 2002.
15. Krezel W, Kastner P, Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 89: 1291-1300, 1999.
16. Penniston K, Tanumihardjo S. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 83:191-201, 2006.
17. Lam HS, Chow CM, Poon WT, Lai CK, Chan KC, Yeung WL, Hui J, Chan AY, Ng PC. Risk of vitamin A toxicity from candy-like chewable vitamin supplements for children. Pediatrics 118:820-824, 2006.
18. Wallace A. Mental Illness, biology, and culture. In: Hsu F, Ed. Psychological Anthropology. Cambridge, MA: Shenkman, pp363-402, 1972.
19. Restak RM. Pseudotumor cerebri, psychosis, and hypervitaminosis A. J Nerv Ment Dis 155:72-75, 1972.
20. Wieland RG, Hendricks FH, Amat y Leon F, Gutierrez L, Jones JC. Hypervitaminosis A with hypercalcaemia. Lancet 1:698, 1971.
21. Muenter MD, Perry HO, Ludwig J. Chronic vitamin A intoxication in adults. Hepatic, neurologic and dermatologic complications. Am J Med 50:129-136, 1971.
22. Park EY, Dillard A, Williams EA, Wilder ET, Pepper MR, Lane MA. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism. Cancer Res 65:9923-9933, 2005.
23. Park EY, Wilder ET, Lane MA. Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels. Nutr Cancer 57:66-77, 2007.
24. Dillard AC, Lane MA. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines. Mol Carcinog 46:315-329, 2007.
25. Wysowski D, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. New Engl J Med 334:460-461, 2001.
26. Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Exp Opin Drug Saf 3:119-129, 2004.
27. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 45:S168-175, 2001.
28. O'Connell KA, Wilkin JK, Pitts M. Isotretinoin (Accutane) and serious psychiatric adverse events. J Am Acad Dermatol 48:306-308, 2003.
29. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoic use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 136:1231-1236, 2000.
30. Bremner JD, Fani N, Ashraf A, Votaw JR, Brummer ME, Cummins T, Vaccarino V, Goodman MM, Reed L, Siddiq S, Nemeroff CB. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry 162:983-991, 2005.
31. O'Reilly K, Shumake J, Gonzalez-Lima F, Lane MA, Bailey SJ. Chronic administration of 13-cis-retinoic acid enhances depression-related behavior in mice. Neuropsychopharmacology 31:1919-1927, 2006.
32. Ferguson S, Cisneros F, Gough B, Hanig J, Berry K. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. Toxicol Sci 87: 451-459, 2005.
33. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463, 2000.
34. Ripoll N, David DJ, Dailly E, Hascoet M, Bourin M. Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 143:193-200, 2003.
35. Crowley JJ, Blendy JA, Lucki I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl) 183:257-264, 2005.
36. Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155:315-322, 2001.
37. Lopez-Rubalcava C, Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22:191-199, 2000.
38. Sousa JC, Grandela C, Fernandez-Ruiz J, de Miguel R, de Sousa L, Magalhaes AI, Saraiva MJ, Sousa N, Palha JA. Transthyretin is involved in depression-like behaviour and exploratory activity. J Neurochem 88:1052-1058, 2004.
39. Laifenfeld D, Klein E, Ben-Shachar D. Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J Neurochem 83:1054-1064, 2002.
40. Maas JW, Fawcett JA, Dekirmenjian H. Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry 26:252-262, 1972.
41. Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72, 1995.
42. Ferguson S, Cisneros F, Gough B, Ali S. Four weeks of oral isotretinoin treatment causes few signs of general toxicity in male and female sprague-dawley rats. Food Chem Toxicol 43:1289-1286, 2005.
43. Kitaoka K, Hattori A, Chikahisa S, Miyamoto KI, Nakaya Y, Sei H. Vitamin A deficiency induces a decrease in EEG delta power during sleep in mice. Brain Res 1150C:121-130, 2007.
44. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci:861, 1998.
45. Qin P, Haberbusch J, Soprano D, Soprano K. Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally. J Cell Biochem 92:147-163, 2004.
46. Motomura K, Mitsuru O, Satre M, Tsukamoto H. Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease. Am J Physiol Endocrinol Metab 281: E420-E429, 2001.
47. Crowe D. Retinoic acid mediates post-transcriptional regulation of keratin 19 mRNA levels. J Cell Sci 106:183-188, 1993.
48. Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 25: 781-823, 2001.
49. Nestler EJ, Carlezon WA, Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159, 2006.
50. 3H]N-0437, to dopamine D2 receptors in the rat brain. Eur J Pharmacol 304:49-54, 1996.
51. Samad TA, Krezel W, Chambon P, Borrelli E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci U S A 94:14349-14354, 1997.
52. Valdenaire O, Maus-Moatti M, Vincent JD, Mallet J, Vernier P. Retinoic acid regulates the developmental expression of dopamine D2 receptor in rat striatal primary cultures. J Neurochem 71:929-936, 1998.
53. Dziedzicka-Wasylewska M, Solich J. Neuronal cell lines transfected with the dopamine D2 receptor gene promoter as a model for studying the effects of antidepressant drugs. Brain Res Mol Brain Res 128: 75-82, 2004.
54. Krezel W, Ghyselinck N, Samad TA, Dupe V, Kastner P, Borrelli E, Chambon P. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279:863-867, 1998.
55. Kobayashi M, Matsuoka I, Kurihara K. Cholinergic differentiation of cultured sympathetic neurons induced by retinoic acid. Induction of choline acetyltransferase-mRNA and suppression of tyrosine hydroxylase-mRNA levels. FEBS Letters 337:259-264, 1994.
56. Berrard S, Faucon Biguet N, Houhou L, Lamouroux A, Mallet J. Retinoic acid induces cholinergic differentiation of cultured newborn rat sympathetic neurons. J Neurosci Res 35:382-389, 1993.
57. Cervini R, Berrard S, Bejanin S, Mallet J. Regulation by CDF/LIF and retinoic acid of multiple ChAT mRNAs produced from distinct promoters. Neuroreport 5:1346-1348, 1994.
58. Jeong H, Kim MS, Kim SW, Kim KS, Seol W. Regulation of tyrosine hydroxylase gene expression by retinoic acid receptor. J Neurochem 98:386-394, 2006.
59. Nicotra A, Falasca L, Senatori O, Conti Devirgiliis L. Monoamine oxidase A and B activities in embryonic chick hepatocytes: differential regulation by retinoic acid. Cell Biochem Funct 20:87-94, 2002.
60. Seifritz E. Contribution of sleep physiology to depressive pathophysiology. Neuropsychopharmacology 25:S85-88, 2001.
61. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 65:927-947, 2005.
62. Argyropoulos SV, Wilson SJ. Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatry 17:237-245, 2005.
63. Gupta MA, Gupta AK. Isotretinoin use and reports of sustained dreaming. Br J Dermatol 144:919-920, 2001.
64. Idzikowski C, Shapiro CM. ABC of sleep disorders. Non-Psychotropic drugs and sleep. BMJ 306:1118-1121, 1993.
65. Maret S, Franken P, Dauvilliers Y, Ghyselinck NB, Chambon P, Tafti M. Retinoic acid signaling affects cortical synchrony during sleep. Science 310:111-113, 2005.
66. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93:3908-3913, 1996.
67. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 157:115-118, 2000.
68. Kempermann G, Jessberger S, Steiner B, Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trend Neurosci 27:447-452, 2004.
69. Kempermann G, Wiskott L, Gage FH. Functional significance of adult neurogenesis. Curr Opin Neurobiol 14:186-191, 2004.
70. Chaing M, Misner D, Kempermann G, Schikorski T, Giguere V, Sucov H, Gage F, Stevens C, Evans R. An essentail role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 21:1353-1361, 1998.
71. Cocco S, Diaz G, Stancampiano R, Diana A, Carta M, Curreli R, Sarais L, Fadda F. Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience 115:475-482, 2003.
72. Etchamendy N, Enderlin V, Marighetto A, Pallet V, Higueret P, Jaffard R. Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signaling. Behav Brain Res 145:37-49, 2003.
73. Castren E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21, 2007.
74. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127, 2006.
75. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110, 2000.
76. Holick KA, Lee DC, Hen R, Dulawa SC. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology, 2007.
77. Palmer TD, Takahashi J, Gage FH. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci 8:389-404, 1997.
78. Takahashi J, Palmer TD, Gage FH. Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J Neurobiol 38:65-81, 1999.
79. Bremner JD. Does isotretinoin cause depression and suicide? Psychopharmacol Bull 37:64-78, 2003.